Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Removed the 403 error page elements (doctype, meta tags and Home link), resulting in the study details page becoming accessible again.
    Difference
    0.5%
    Check dated 2026-09-28T16:30:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The Study Record page is now rendering a 403 Forbidden error instead of the usual study details, signaling an access issue. The UI reflects an error state rather than updated or added study content.
    Difference
    18%
    Check dated 2026-09-21T20:20:34.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a minor update to the page's version metadata rather than substantive changes to study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:00:23.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The study page now displays an error/unavailable message, replacing the usual study details and navigation.
    Difference
    17%
    Check dated 2026-08-10T10:40:41.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This indicates a small internal update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-07-27T06:16:54.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a page update or correction on ClinicalTrials.gov but does not modify the underlying study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-07-05T04:38:22.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.